Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aerosolized Liposomal Rubitecan in NSCLC
NCT00250068Phase 2Completed
- Sponsor
- The University of New Mexico
- Start
- Apr 2003
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rubitecan in non-small cell lung cancer (NSCLC), sponsored by The University of New Mexico. Started Apr 2003; status: completed.
02
Drugs
rubitecan
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00250068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00250068.